Finance

Lists
Why is KRRO down 10,53%?
Dive Deeper
KRRO:NASDAQ
Korro Bio Inc
14,87 USD
-10,53%
(-1,75) 1D
5-ноя., 14:51:03 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KRRO...
Open
16,00 USD
High
16,00 USD
Low
11,50 USD
Mkt. cap
218,97 млн
Avg. vol.
198,02 миң
Volume
320,54 миң
52-wk high
36,79 USD
52-wk low
5,20 USD
EPS
-10,00 USD
Beta
3,23
Shares outstanding
14,73 млн
No. of employees
57
Open
16,00 USD
High
16,00 USD
Low
11,50 USD
Mkt. cap
218,97 млн
Avg. vol.
198,02 миң
Volume
320,54 миң
52-wk high
36,79 USD
52-wk low
5,20 USD
EPS
-10,00 USD
Beta
3,23
Shares outstanding
14,73 млн
No. of employees
57
News stories
From web sources and news partners
About Korro Bio Inc
CEO-
Employees57
Founded2014
Headquarters-
SectorHealth Care
Industry-
Websitekorrobio.com
Analyst ratings
Based on 10 analysts giving stock ratings to KRRO in the past 3 months
Strong buy
Buy
9
Hold
1
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for KRRO in the last 3 months.
Highest
Current 14,87 USD
30,00 USD (+101,75%)
Average
19,33 USD (+29,99%)
Lowest
10,00 USD (-32,75%)
Analyst
Recommendation
Action
Price target
Projected
Date
Kostas Biliouris
Oppenheimer
Buy
Reiterated
22,00 USD
+47,9%
10/28/2026
Mitchell Kapoor
H.C. Wainwright
Buy
Reiterated
15,00 USD
+0,9%
10/23/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
30,00 USD
+101,7%
10/06/2026
Unknown Analyst
LifeSci Capital
Buy
Maintained
21,00 USD
+41,2%
10/06/2026
Unknown Analyst
Oppenheimer
Buy
Reiterated
22,00 USD
+47,9%
10/06/2026
Yigal Nochomovitz
Citi
Buy
Maintained
21,00 USD
+41,2%
09/09/2026
Luca Issi
RBC Capital
Hold
Maintained
10,00 USD
-32,8%
08/07/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
22,00 USD
+47,9%
08/06/2026
William Maughan
Clear Street
Buy
Maintained
18,00 USD
+21%
08/07/2026
Myles Minter
William Blair
Buy
Maintained
-
-
08/06/2026
Keay Nakae
Chardan Capital
Buy
Reiterated
15,00 USD
+0,9%
08/06/2026
Catherine Novack
JonesTrading
Buy
Upgraded
23,00 USD
+54,7%
05/08/2026
Ryan Deschner
Raymond James
Buy
Upgraded
23,00 USD
+54,7%
03/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
1,09 млн
1,29 млн
-
-
Cost of goods sold
11,26 млн
8,60 млн
11,53 млн
11,63 млн
Cost of revenue
11,26 млн
8,60 млн
11,53 млн
11,63 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9,06 млн
8,58 млн
8,91 млн
8,48 млн
Operating expense
9,06 млн
8,58 млн
8,91 млн
8,48 млн
Total operating expenses
20,33 млн
17,18 млн
20,44 млн
20,11 млн
Operating income
-19,24 млн
-15,88 млн
-20,44 млн
-20,11 млн
Other non operating income
1,18 млн
990,00 миң
-
-
EBT including unusual items
-18,06 млн
-49,41 млн
-19,53 млн
-18,81 млн
EBT excluding unusual items
-18,06 млн
-14,89 млн
-19,53 млн
-18,81 млн
Income tax expense
-
636,00 миң
95,00 миң
108,00 миң
Effective tax rate
-
-1,29%
-0,49%
-0,57%
Other operating expenses
-
-
-
-
Net income
-18,06 млн
-50,04 млн
-19,62 млн
-18,92 млн
Net profit margin
-1 656,97%
-3 873,22%
-
-
Earnings per share
-1,92
-1,65
-1,69
-1,07
Interest and investment income
-
-
906,00 миң
1,30 млн
Interest expense
-
-
-
-
Net interest expenses
-
-
906,00 миң
1,30 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-18,06 млн
-15,23 млн
-20,06 млн
-19,74 млн
Gain or loss from assets sale
-
-18,00 миң
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору